Clinical Trials Browser

Phase 3 × Pancreatic Neoplasms × lanreotide × Clear all

NCT06807437 2026-03-31

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms